WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
TSX:WELL - Toronto Stock Exchange - CA94947L1022 - Common Stock - Currency: CAD
Overall WELL gets a fundamental rating of 5 out of 10. We evaluated WELL against 17 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of WELL get a neutral evaluation. Nothing too spectacular is happening here. WELL is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes WELL very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year WELL was profitable.
WELL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: WELL reported negative net income in multiple years.
In multiple years WELL reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of WELL (4.61%) is better than 81.25% of its industry peers.
WELL has a better Return On Equity (8.67%) than 81.25% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.80%, WELL is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.61% | ||
| ROE | 8.67% | ||
| ROIC | 2.8% |
ROA(3y)-1.11%
ROA(5y)-3.61%
ROE(3y)-2.32%
ROE(5y)-6.61%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 7.67%, WELL belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
The Operating Margin of WELL (4.50%) is better than 68.75% of its industry peers.
WELL has a better Gross Margin (44.16%) than 81.25% of its industry peers.
WELL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.5% | ||
| PM (TTM) | 7.67% | ||
| GM | 44.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.34%
GM growth 5Y10.4%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WELL is destroying value.
Compared to 1 year ago, WELL has more shares outstanding
WELL has more shares outstanding than it did 5 years ago.
WELL has a worse debt/assets ratio than last year.
2.2 Solvency
WELL has an Altman-Z score of 1.93. This is not the best score and indicates that WELL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.93, WELL is doing good in the industry, outperforming 68.75% of the companies in the same industry.
WELL has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as WELL would need 3.48 years to pay back of all of its debts.
WELL has a better Debt to FCF ratio (3.48) than 75.00% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that WELL is not too dependend on debt financing.
WELL has a better Debt to Equity ratio (0.44) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 3.48 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.36
WACC7.68%
2.3 Liquidity
WELL has a Current Ratio of 1.14. This is a normal value and indicates that WELL is financially healthy and should not expect problems in meeting its short term obligations.
WELL's Current ratio of 1.14 is fine compared to the rest of the industry. WELL outperforms 68.75% of its industry peers.
WELL has a Quick Ratio of 1.13. This is a normal value and indicates that WELL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.13, WELL belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
WELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 500.00%, which is quite impressive.
WELL shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.56%.
WELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 136.00% yearly.
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1000%
Revenue 1Y (TTM)36.56%
Revenue growth 3Y149.11%
Revenue growth 5Y136%
Sales Q2Q%23.12%
3.2 Future
The Earnings Per Share is expected to grow by 37.69% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.31% on average over the next years. This is quite good.
EPS Next Y212.7%
EPS Next 2Y70.12%
EPS Next 3Y47.56%
EPS Next 5Y37.69%
Revenue Next Year29.47%
Revenue Next 2Y22.74%
Revenue Next 3Y17.52%
Revenue Next 5Y14.31%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL is valuated quite expensively with a Price/Earnings ratio of 51.00.
Compared to the rest of the industry, the Price/Earnings ratio of WELL indicates a somewhat cheap valuation: WELL is cheaper than 68.75% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.62, WELL is valued quite expensively.
Based on the Price/Forward Earnings ratio of 38.03, the valuation of WELL can be described as expensive.
Based on the Price/Forward Earnings ratio, WELL is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, WELL is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51 | ||
| Fwd PE | 38.03 |
4.2 Price Multiples
WELL's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, WELL is valued a bit cheaper than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.42 | ||
| EV/EBITDA | 16.72 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of WELL may justify a higher PE ratio.
WELL's earnings are expected to grow with 47.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y70.12%
EPS Next 3Y47.56%
5. Dividend
5.1 Amount
No dividends for WELL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (2/21/2025, 7:00:00 PM)
6.12
+0.03 (+0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners6.33%
Inst Owner ChangeN/A
Ins Owners8.41%
Ins Owner ChangeN/A
Market Cap1.53B
Analysts81
Price Target8.85 (44.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8921.57%
Min EPS beat(2)-3335.29%
Max EPS beat(2)21178.4%
EPS beat(4)2
Avg EPS beat(4)4048.19%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)3
Avg EPS beat(8)1725.39%
EPS beat(12)3
Avg EPS beat(12)1063.25%
EPS beat(16)4
Avg EPS beat(16)719.15%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.74%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.49%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)8
Avg Revenue beat(12)1.53%
Revenue beat(16)11
Avg Revenue beat(16)2.07%
PT rev (1m)2.5%
PT rev (3m)13.99%
EPS NQ rev (1m)62.08%
EPS NQ rev (3m)1.02%
EPS NY rev (1m)-13.53%
EPS NY rev (3m)-58.78%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51 | ||
| Fwd PE | 38.03 | ||
| P/S | 1.6 | ||
| P/FCF | 13.42 | ||
| P/OCF | 12.13 | ||
| P/B | 1.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.72 |
EPS(TTM)0.12
EY1.96%
EPS(NY)0.16
Fwd EY2.63%
FCF(TTM)0.46
FCFY7.45%
OCF(TTM)0.5
OCFY8.24%
SpS3.83
BVpS3.39
TBVpS-0.81
PEG (NY)0.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.61% | ||
| ROE | 8.67% | ||
| ROCE | 3.28% | ||
| ROIC | 2.8% | ||
| ROICexc | 2.94% | ||
| ROICexgc | 18.37% | ||
| OM | 4.5% | ||
| PM (TTM) | 7.67% | ||
| GM | 44.16% | ||
| FCFM | 11.9% |
ROA(3y)-1.11%
ROA(5y)-3.61%
ROE(3y)-2.32%
ROE(5y)-6.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.34%
GM growth 5Y10.4%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 3.48 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 17.87% | ||
| Cap/Sales | 1.27% | ||
| Interest Coverage | 1.62 | ||
| Cash Conversion | 113.38% | ||
| Profit Quality | 155.17% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.93 |
F-Score6
WACC7.68%
ROIC/WACC0.36
Cap/Depr(3y)10.65%
Cap/Depr(5y)16.03%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1000%
EPS Next Y212.7%
EPS Next 2Y70.12%
EPS Next 3Y47.56%
EPS Next 5Y37.69%
Revenue 1Y (TTM)36.56%
Revenue growth 3Y149.11%
Revenue growth 5Y136%
Sales Q2Q%23.12%
Revenue Next Year29.47%
Revenue Next 2Y22.74%
Revenue Next 3Y17.52%
Revenue Next 5Y14.31%
EBIT growth 1Y56.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year264.45%
EBIT Next 3Y69.86%
EBIT Next 5Y44.52%
FCF growth 1Y130.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.39%
OCF growth 3YN/A
OCF growth 5YN/A